免疫異常疾患研究室 2020(令和2)年度業績（欧文文献）(太字アンダーラインは当院所属)
1.

Y. Saeki; Y. Okita; E. Igashira-Oguro; C. Udagawa; A. Murata; T. Tanaka;
J. Mukai; K. Miyazawa; Y. Hoshida; S. Ohshima.
Modulation of TNFR 1-triggered two opposing signals for inflammation andapoptosis via RIPK 1 disruption by geldanamycin in rheumatoid arthritis.
Clinical Rheumatology. 40(6):2395-2405, 2021 Jan

2.

T.Igarashi, S.Takei, E.Tanaka, U.Kaneko, T.Kubota,K.Okamoto, S.Ohshima,
M.Mori.
Investigation of dual-energy X-ray absorptiometry units necessary for pediatricrheumatologists in Japan and a proposal for shared access to equipment amonghospitals. J Nippon Med Sch. 2020 Aug.

3.

Matsuoka H, Kabata D, Taura A, Matsui T, Takahi K, Hirano F, Katayama M,
Okamoto A, Suenaga Y, Suematsu E, Yoshizawa S, Ohmura K, Ito S, Takaoka H,Oguro E, Kuzuya K, Okita Y, Udagawa C, Yoshimura M, Teshigawara S,Harada Y, Isoda K, Yoshida Y, Ohshima S, Tohma S, Saeki Y.
Lack of association between a disease-susceptible single-nucleotidepolymorphism, rs2230926 of TNFAIP3, and tumour necrosis factor inhibitor
therapeutic failure in Japanese patients with rheumatoid arthritis
Scand J Rheumatol. 49(3):253-255, 2020 Jan, Epub Date 2020 Mar

4.

K. Ebina; J. Hashimoto; M. Kashii; M. Hirao; A. Miyama; H. Nakaya; S. Tsuji;
K. Takahi; H. Tsuboi; G. Okamura; Y. Etani; K. Takami; H. Yoshikawa.
Effects of follow-on therapy after denosumab discontinuation in patients withpostmenopausal osteoporosis.
Modern Rheumatology. 31(2):485-492, 2021 Mar5.

T. Kishikawa; N. Arase; S. Tsuji; Y. Maeda; T. Nii; J. Hirata; K. Suzuki;
K. Yamamoto; T. Masuda; K. Ogawa; S. Ohshima; H. Inohara; A. Kumanogoh;
M. Fujimoto; Y. Okada.
Large-scale plasma-metabolome analysis identifies potential biomarkers ofpsoriasis and its clinical subtypes. J Dermatol Sci. 2021 Mar6.

T. Kojima; H. Ishikawa; S. Tanaka; N. Haga; K. Nishida; M. Yukioka;
J. Hashimoto; H. Miyahara; Y. Niki; T. Kimura; H. Oda; S. Asai; K. Funahashi;
M. Kojima; N. Ishiguro.
Relationship between the physician-based clinical scale for foot and ankle
surgery and patient-reported outcomes in patients with long-standing
rheumatoid arthritis: Results from a multicenter prospective observational
cohort study.
Modern Rheumatology. 31(3):607-613, 2021 May,Epub Date 2020 Jul

7.

D.Rooks; T.Swan; B.Goswami; L.A.Filosa; O.Bunte; N. Panchaud; L. A. Coleman;
R. R. Miller; E. Garcia Garayoa; J. Praestgaard; R. G. Perry; C. Recknor; C. M.
Fogarty; H. Arai; L. K. Chen; J. Hashimoto; Y. S. Chung; J. Vissing; D. Laurent;
O. Petricoul; S. Hemsley; E. Lach-Trifilieff; D. A. Papanicolaou; R. Roubenoff.
Bimagrumab vs Optimized Standard of Care for Treatment of Sarcopenia in
Community-Dwelling Older Adults A Randomized Clinical Trial.
Jama Network Open. 3(10) 13, 2020 Oct

8.

T. Ishibashi; T. Tomita; T. Yamazaki; S. Tsuji; H. Yoshikawa; K. Sugamoto.
Kinematics of bicruciate and posterior stabilized total knee arthroplasty during
deep knee flexion and stair climbing.
Journal of Orthopaedic Research. 9, 2020 Jun

9.

P. J. Mease; A. Lertratanakul; J. K. Anderson; K. Papp; F. Van den Bosch;
S. Tsuji; E. Dokoupilova; M. Keiserman; X. Wang; S. Zhong; R. M. McCaskill;
P. Zueger; A. L. Pangan; W. Tillett.
Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA 2.
Annals of the Rheumatic Diseases. 80(3):312-320, 2021 Mar

10.

V. Furer; M. Kishimoto; S. Tsuji; Y. Taniguchi; Y. Ishihara; T. Tomita;
P. S. Helliwell; O. Elkayam.
The Diagnosis and Treatment of Adult Patients with SAPHO Syndrome:
Controversies Revealed in a Multidisciplinary International Survey ofPhysicians.
Rheumatology and Therapy. 7(4):883-891,2020 Dec

11.

T. Arai; H. Kida; Y. Ogata; S. Marumo; H. Matsuoka; I. Gohma; S. Yamamoto;
M. Mori; C. Sugimoto; K. Tachibana; M. Akira; Y. Inoue.
Efficacy of recombinant thrombomodulin for poor prognostic cases of acuteexacerbation in idiopathic interstitial pneumonia: secondary analysis of theSETUP trial.
Bmj Open Respiratory Research. 7(1):11, 2020 Mar, Epub Date 2020 May

12.

T. Hasegawa; N. Yanagitani; F. Ohyanagi; K. Kudo; A. Horiike; Y. Tambo;
S. Nishikawa; R. Ariyasu; K. Uchibori; S. Kitazono; M. Nishio.
Phase II study of the combination of S-1 with bevacizumab for patients withpreviously treated advanced non-squamous non-small-cell lung cancer.
International Journal of Clinical Oncology. 26(3):507-514, 2021 Mar

13.

H. Hayashi; M. Ogura; T. Niwa; T. Yokoyama; J. Tanizaki; T. Ozaki; H. Yoshioka;
T. Kurata; Y. Tamura; Y. Fujisaka; K. Tanaka; Y. Hasegawa; K. Kudo; Y. Chiba;
K. Nakagawa.
Phase I/IIStudy of Cisplatin plusNab-Paclitaxelwith Concurrent Thoracic
Radiotherapy for Patients with Locally AdvancedNon-SmallCell Lung Cancer.
Oncologist. 26(1):19-e52, 2021 Jan

14.

Y. Okuma; Y. Goto; F. Ohyanagi; K. Sunami; Y. Nakahara; S. Kitazono; K. Kudo;
Y. Tambo; S. Kanda; N. Yanagitani; A. Horiike; H. Horinouchi; Y. Fujiwara;
H. Nokihara; N. Yamamoto; M. Nishio; Y. Ohe; Y. Hosomi.
Phase II trial of S-1 treatment as palliative-intent chemotherapy for previously
treated advanced thymic carcinoma. Cancer Medicine. 9(20):7418-7427, 2020 Oct

15.

T. Ota; T. Fukui; Y. Nakahara; T. Takeda; J. Uchino; T. Mouri; K. Kudo;
S. Nakajima; T. Suzumura; M. Fukuoka.
Serum immune modulators during the first cycle of anti-PD-1 antibody therapy
in non-small cell lung cancer: Perforin as a biomarker.
Thoracic Cancer. 11(11):3223-3233,2020 Nov

16.

S. Nakajima, T. Utsunomiya, K. Yoshinoya,H. Honda, R. Ogino, K. Kudo.
Pneumonitis following Pembrolizumab andradiation therapy in a patient withlung cancer and rib metastasis.
Medicine casereport and study protcaol. 1(1):e004, 2020 Nov